Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views

Last Hour:
Last 24 Hours:

Oragenics shares jump 28% on FDA fast track designation

Monday, November 21, 2016 7:45
% of readers think this story is Fact. Add your two cents.

Oragenics Inc (NYSEMKT:OGEN) shares were up 28% pre-market on Monday after the company announced that US Food and Drug Administration (FDA) granted Fast Track designation to AG013, its lead therapeutic candidate for the treatment of OM.

Oragenics expects to file an Investigational New Drug (IND) update and initiate a Phase 2 study with AG013 in the United States and Europe in early 2017.

Oragenics is a leader in the development of novel antibiotics against infectious disease and developing effective treatments for oral mucositis (OM), today

Fast Track is a process designed to facilitate the development and review of drugs to treat serious conditions and address key unmet medical needs by allowing for more frequent meetings and communications with the FDA. It also provides eligibility submission of a New Drug Application on a rolling basis as well as Accelerated Approval and Priority Review.

Oragenics shares were up 27.9% at $0.55 pre-market on Monday.

Story by ProactiveInvestors


We encourage you to Share our Reports, Analyses, Breaking News and Videos. Simply Click your Favorite Social Media Button and Share.

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global

Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.